# YUVIWEL
> **NDA219164** · New Drug Application · Sponsor: ASCENDIS · Approved 2026-02-27
## Drug
- **FDA Application Number:** NDA219164
- **Application type:** New Drug Application
- **Brand name:** YUVIWEL
- **Generic name:** NAVEPEGRITIDE
- **Active ingredients:** NAVEPEGRITIDE
- **Dosage form:** POWDER
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** ASCENDIS
- **Manufacturer:** Ascendis Pharma Endocrinology, Inc.
- **First approval:** 2026-02-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219164)
---
*AI Analytics · CC0 1.0*